Clinical Trial Results:
A Phase IV, Single Centre, Open-label Study to Investigate the Kinetics of the B Cell Response to the C saccharide component of Chiron’s Meningococcal C Conjugate Vaccine (Menjugate®) Administered to Healthy Children at least 12 Months of Age After Priming with Menjugate® at 2, 3 and 4 Months of Age.
Summary
|
|
EudraCT number |
2006-000732-28 |
Trial protocol |
GB |
Global completion date |
10 Aug 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
Yes
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
17 Apr 2019
|
First version publication date |
17 Apr 2019
|
Other versions |
|
Summary report(s) |
M14P5E1 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.